By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

Reject
United Kingdom | EnglishEN

Current country and language: United KingdomUnited Kingdom | English (EN)

ChinaChina
GermanyGermany
IrelandIreland
ItalyItaly
SpainSpain
United KingdomUnited Kingdom

YOU ARE LEAVING THE CURRENT LANGUAGE


Procarbazine

procarbazine hydrochloride

Procarbazine is indicated in the treatment of Hodgkin's disease (lymphadenoma) and may also be useful in other advanced lymphomata and a variety of solid tumours which have proved resistant to other forms of therapy.

Strength: 50mg

Pack size: 50 capsules

PIP code : 108-2353

Legal status: POM

Summary of Products Characteristics Patient information Leaflet

Always read the label

Adverse events (side effects) thought to have been caused by one of our products should be reported to the MHRA via their yellow card scheme and to Alliance’s Pharmacovigilance team. Click here to submit a report